Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis

Infection and Immunity

Volumn 75, Issue 11, 2007, Pages 5434-5442

  Weynants, Vincent E ^a   Feron, Christiane M ^a   Goraj, Karine K ^a   Bos, Martine P ^b   Denoël, Philippe A ^a   Verlant, Vincent G ^a   Tommassen, Jan ^b   Peak, Ian R A ^c   Judd, Ralph C ^d   Jennings, Michael P ^e   Poolman, Jan T ^a  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^b UTRECHT UNIVERSITY   (Netherlands)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF MONTANA   (United States)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; OUTER MEMBRANE PROTEIN; PORIN A;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; INFECTION RESISTANCE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; DRUG SYNERGISM; FEMALE; GENE DELETION; MEMBRANE PROTEINS; MENINGOCOCCAL INFECTIONS; MICE; MICROBIAL VIABILITY; NEISSERIA MENINGITIDIS; PORINS;

EID: 35648941263     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00411-07     Document Type: Article

References (46)

1. Ala'Aldeen, D. A. A., P. Stevenson, E. Griffiths, A. R. Gorringe, L. I. Irons, A. Robinson, S. Hyde, and S. P. Borriello. 1994. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect. Immun. 62:2984-2990.
2. Bernadac, A., M. Gavioli, J. C. Lazzaroni, S. Raina, and R. Lloubès. 1998. Escherichia coli tol-pal mutants form outer membrane vesicles. J. Bacteriol. 180:4872-4878.
3. Bos, M. P., and J. Tommassen. 2004. Biogenesis of the Gram-negative bacterial outer membrane. Curr. Opin. Microbiol. 7:610-616.
4. Comanducci, M., S. Bambini, B. Brunelli, J. Adu-Bobie, B. Aricò, B. Capecchi, M. M. Giuliani, V. Masignani, L. Santini, S. Savino, D. M. Granoff, D. A. Caugant, M. Pizza, R. Rappuoli, and M. Mora. 2002. NadA, a novel vaccine candidate of Neisseria meningitidis. J. Exp. Med. 195:1445-1454.
5. Connolly, M., and N. Noah on behalf of the European Meningitis Surveillance Group. 1999. Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. Epidemiol. Infect. 122:41-49.
6. Cooper, N. R. 1985. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37:151-216.
7. Danve, B., L. Lissolo, M. Mignon, P. Dumas, S. Colombani, A. B. Schryvers, and M. J. Quentin-Millet. 1993. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine 11:1214-1220.
8. de Moraes, J. C., B. A. Perkins, M. C. C. Camargo, N. T. R. Hidalgo, H. A. Barbosa, C. T. Sacchi, I. M. Land Gral, V. L. Gattas, H. D. G. Vasconcelos, B. D. Plikaytis, J. D. Wenger, and C. V. Broome. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
9. Dubuisson, J. F., A. Vianney, N. Hugouvieux-Cotte-Pattat, and J. C. Lazzaroni. 2005. Tol-Pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence. Microbiology 151:3337-3347.
10. EU-IBIS Network. 2006. Invasive Neisseria meningitidis in Europe 2003/2004. Health Protection Agency, London, United Kingdom.
11. Finne, J., M. Leinonen, and P. H. Mäkelä. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 322:355-357.
12. Fitzpatrick, D. A., and J. O. McInerney. 2005. Evidence of positive Darwinian selection in Omp85, a highly conserved bacterial outer membrane protein essential for cell viability. J. Mol. Evol. 60:268-273.
13. Frasch, C. E., L. van Alphen, J. Holst, J. T. Poolman, and E. Rosenqvist. 2001. Outer membrane protein vesicle vaccines for meningococcal disease, p. 81-107. In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal vaccines: methods and protocols. Humana Press, Totowa, NJ.
14. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504-510.
15. Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjune, L. O. Froholm, A. K. Lindbak, B. Mogster, E. Namork, U. Rye, G. Stabbetorp, R. Winsnes, B. Arise, and O. Gloss. 1991. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14:67-79.
16. Frosch, M., E. Schultz, E. Glenn-Calvo, and T. F. Meyer. 1990. Generation of capsule-deficient Neisseria meningitidis strains by homologous recombination. Mol. Microbiol. 4:1215-1218.
17. Gentle, I., K. Gabriel, P. Beech, R. Waller, and T. Lithgow. 2004. The Omp85 family of proteins is essential for outer membrane biogenesis in mitochondria and bacteria. J. Cell Biol. 164:19-24.
18. Gorringe, A. R., R. Borrow, A. J. Fox, and A. Robinson. 1995. Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine 13:1207-1212.
19. Jain, S., P. van Ulsen, I. Benz, M. A. Schmidt, R. Fernandez, J. Tommassen, and M. B. Goldberg. 2006. Polar localization of the autotransporter family of large bacterial virulence proteins. J. Bacteriol. 188:4841-4850.
20. Kortekaas, J., S. A. Müller, P. Ringler, M. Gregorini, V. E. Weynants, L. Rutten, M. P. Bos, and J. Tommassen. 2006. Immunogenicity and structural characterisation of an in vitro folded meningococcal siderophore receptor (FrpB, FetA). Microbes Infect. 8:2145-2153.
21. Legrain, M., V. Mazarin, S. W. Irwin, B. Bouchon, M. J. Quentin-Millet, E. Jacobs, and A. B. Schryvers. 1993. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene 130:73-80.
22. Manning, D. S., D. K. Reschke, and R. C. Judd. 1998. Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis are similar to Haemophilus influenzae D-15-Ag and Pasteurella multocida Oma87. Microb. Pathog. 25:11-21.
23. Martin, D., N. Cadieux, J. Hamel, and B. R. Brodeur. 1997. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection. J. Exp. Med. 185:1173-1184.
24. Moe, G. R., S. Tan, and D. M. Granoff. 1999. Differences in surface expression of NspA among Neisseria meningitidis group B strains. Infect. Immun. 67:5664-5675.
25. Moe, G. R., P. Zuno-Mitchell, S. N. Hammond, and D. M. Granoff. 2002. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect. Immun. 70:6021-6031.
26. Nedelec, J., J. Boucraut, J. M. Garnier, D. Bernard, and G. Rougon. 1990. Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis. J. Neuroimmunol. 29:49-56.
27. Noah, N., and B. Henderson. 2002. Surveillance of bacterial meningitis in Europe 1999/2000. Communicable Disease Surveillance Centre, London, United Kingdom.
28. Norheim, G., A. Aase, D. A. Caugant, E. A. Høiby, E. Fritzsønn, T. Tangen, P. Kristiansen, U. Heggelund, and E. Rosenqvist. 2005. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine 23:3762-3774.
29. Oster, P., D. Lennon, J. O'Hallahan, K. Mulholland, S. Reid, and D. Martin. 2005. MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23:2191-2196.
30. Pajón, R., G. Chinea, E. Marrero, D. Gonzalez, and G. Guillén. 1997. Sequence analysis of the structural tbpA gene: protein topology and variable regions within neisserial receptors for transferrin iron acquisition. Microb. Pathog. 23:71-84.
31. Peak, I. R. A., Y. Srikhanta, M. Dieckelmann, E. R. Moxon, and M. P. Jennings. 2000. Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis. FEMS Immunol. Med. Microbiol. 28:329-334.
32. Perrett, K. P., and A. J. Pollard. 2005. Towards an improved serogroup B Neisseria meningitidis vaccine. Expert Opin. Biol. Ther. 5:1611-1625.
33. Pollard, A. J. 2004. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr. Infect. Dis. J. 23:S274-S279.
34. Poolman, J., and F. X. Berthet. 2001. Alternative vaccine strategies to prevent serogroup B meningococcal diseases. Vaccine 20:S24-S26.
35. Poolman, J. T., C. Feron, G. Desquesne, P. A. Denoël, S. Dessoy, K. K. Goraj, D. E. Janssens, S. Kummert, Y. Lobet, E. Mertens, D. Y. Monnom, P. Momin, N. Pépin, J.-L. Ruelle, J. J. Thonnard, V. G. Verlant, P. Voet, and F. X. Berthet. 2002. Outer membrane vesicles and other options for a meningococcal B vaccine, p. 135-149. In C. Ferreirós, M. T. Criado, and J. Vázquez (ed.), Emerging strategies in the fight against meningitis: molecular and cellular aspects. Horizon Scientific Press, Wymondham, Norfolk, United Kingdom.
36. Rokbi, B., G. Renauld-Mongenie, M. Mignon, B. Danve, D. Poncet, C. Chabanel, D. A. Caugant, and M. J. Quentin-Millet. 2000. Allelic diversity of the two transferrin binding protein B gene isotypes among a collection of Neisseria meningitidis strains representative of serogroup B disease: implication for the composition of a recombinant TbpB-based vaccine. Infect. Immun. 68:4938-4947.
37. Rosenqvist, E., E. A. Høiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Rønnild, G. Bjune, and H. Nøkleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
38. Scarselli, M., R. Rappuoli, and V. Scarlato. 2001. A common conserved amino acid motif module shared by bacterial and intercellular adhesins: bacterial adherence mimicking cell cell recognition? Microbiology 147:250-252.
39. Schryvers, A. B., and I. Stojiljkovic. 1999. Iron acquisition systems in the pathogenic Neisseria. Mol. Microbiol. 32:1117-1123.
40. Stevenson, P., P. Williams, and E. Griffiths. 1992. Common antigenic domains in transferrin-binding protein 2 of Neisseria meningitidis, Neisseria gonorrhoeae, and Haemophilus influenzae type b. Infect. Immun. 60:2391-2396.
41. Tappero, J. W., R. Lagos, A. M. Ballesteros, B. Plikaytis, D. Williams, J. Dykes, L. L. Gheesling, G. M. Carlone, E. A. Høiby, J. Holst, H. Nøkleby, E. Rosenqvist, G. Sierra, C. Campa, F. Sotolongo, J. Vega, J. Garcia, P. Herrera, J. T. Poolman, and B. A. Perkins. 1999. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281:1520-1527.
42. + Escherichia coli. Infect. Immun. 61:2906-2911.
43. Vandeputte-Rutten, L., M. P. Bos, J. Tommassen, and P. Gros. 2003. Crystal structure of neisserial surface protein A (NspA), a conserved outer membrane protein with vaccine potential. J. Biol. Chem. 278:24825-24830.
44. van Ulsen, P., L. van Alphen, C. T. P. Hopman, A. van der Ende, and J. Tommassen. 2001. In vivo expression of Neisseria meningitidis proteins homologous to the Haemophilus influenzae Hap and Hia autotransporters. FEMS Immunol. Med. Microbiol. 32:53-64.
45. Voulhoux, R., M. P. Bos, J. Geurtsen, M. Mols, and J. Tommassen. 2003. Role of a highly conserved bacterial protein in outer membrane protein assembly. Science 299:262-265.
46. Wong, S., D. Lennon, C. Jackson, J. Stewart, S. Reid, S. Crengle, S. Tilman, I. Aaberge, J. O'Hallahan, P. Oster, K. Mulholland, and D. Martin. 2007. New Zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months. Pediatr. Infect. Dis. J. 26:345-350.